3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lymphatic Metastasis
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Breast Cancer Lymphedema
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Right Hemicolectomy
1
Rhabdomyosarcoma
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Mixed Tumor, Mesodermal
1
Mesothelioma, Malignant
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Giant Cell Tumor of Tendon Sheath
1
Interventions
Magnetic Resonance Spectroscopy
11
trametinib
8
selpercatinib
7
pembrolizumab
7
dabrafenib
7
Nivolumab
7
Iodine-131
6
lenvatinib
5
Specimen Handling
5
Biopsy
5
cabozantinib
4
Vemurafenib
4
Iodine-124
4
larotrectinib
3
durvalumab
3
binimetinib
3
anlotinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
pralsetinib
2
omipalisib
2
defactinib
2
copanlisib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Indocyanine Green
×
1 year
×
Clear all
No trials found.